Faculty of Veterinary Medicine, Department of Clinical Sciences, Semnan University, Semnan, Iran.
Department of Quality Control, Razi Vaccine and Serum Research, Education and Extension Organization (AREEO), Karaj, Iran.
Vet Med Sci. 2023 Jul;9(4):1818-1823. doi: 10.1002/vms3.1179. Epub 2023 Jun 22.
Small ruminant morbillivirus (SRMV) is the etiological agent of Peste des petits ruminants (PPR) disease. PPR is one of the most important viral diseases of small ruminant husbandry. In the endemic countries, vaccination is the main way to control this disease. Administering the first PPR vaccine in goat kids requires decreased maternal immunity.
The aim of this study was to determine the decreasing trend of maternal immunity against SRMV in goat kids born from vaccinated goats.
Twenty Saanen goat kids were studied in two groups including control (n = 5, receiving colostrum from unvaccinated goats) and treatment (n = 15, receiving colostrum from vaccinated goats). Virus neutralisation (VN) test was used to evaluate serum specific antibodies against SRMV in goat kids from birth to 100 days of age.
The first goat kid (n = 1) in the treatment group was seronegative at the age of 28 days. All the goat kids were seronegative at the age of 100 days. The average serum titre of the goat kids at the age of 70-100 days became negative.
Some goat kids became seronegative before reaching the age of receiving the first PPR vaccine. The age of 70-100 days could be a good age range to give the first dose of PPR vaccine to the goat kids, but more studies were needed on the effectiveness of this vaccine at this age range.
小反刍兽疫病毒(SRMV)是小反刍兽疫(PPR)的病原体。PPR 是小反刍动物养殖业中最重要的病毒性疾病之一。在流行国家,疫苗接种是控制这种疾病的主要方法。在山羊幼崽中接种第一剂 PPR 疫苗需要降低母源免疫力。
本研究旨在确定从接种疫苗的山羊所生山羊幼崽的母源抗 SRMV 免疫力的下降趋势。
在两组中研究了 20 只萨能山羊幼崽,包括对照组(n=5,接受未接种疫苗的山羊的初乳)和治疗组(n=15,接受接种疫苗的山羊的初乳)。在出生到 100 天的年龄内,使用病毒中和(VN)试验评估山羊幼崽血清中针对 SRMV 的特异性抗体。
治疗组的第一只山羊幼崽(n=1)在 28 天大时血清学呈阴性。所有山羊幼崽在 100 天大时均呈血清学阴性。70-100 天大的山羊幼崽的平均血清滴度呈阴性。
一些山羊幼崽在达到接种第一剂 PPR 疫苗的年龄之前就已经血清学阴性。70-100 天的年龄可能是给山羊幼崽接种第一剂 PPR 疫苗的良好年龄段,但需要更多研究来评估该年龄段疫苗的有效性。